FY2024 EPS Estimates for Moderna Increased by William Blair
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
24/7 Wall St1d
SoFi Technologies (SOFI) Price Prediction and Forecast 2025-2030
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
Morningstar1mon
William Blair Small-Mid Cap Growth N
William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from its parent firm's long-term risk-adjusted performance, as shown by the firm's average ...
Denali Therapeutics’ (DNLI) Outperform Rating Reiterated at William Blair
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...
bovnews10h
What’s Driving Tenaya Therapeutics Inc (TNYA) Stock’s -51.39% Plunge Over the Past Month?
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
William Blair downgrades Enfusion (ENFN) to a Hold
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
William Blair Has Bullish Forecast for LULU FY2025 Earnings
Equities research analysts at William Blair raised their FY2025 earnings per share (EPS) estimates for Lululemon Athletica in a report issued on Monday, January 13th. William Blair analyst S. Zackfia ...
bovnews7h
FibroGen Inc (FGEN) Stock: Greater Than Its Current Valuation?
BofA Securities has recently reduced FibroGen Inc (FGEN) stock to Underperform rating, as announced on August 8, 2023, according to Finviz. Earlier, on June 26, 2023, William Blair had reduced the ...